AI assistant
Sending…
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2023
May 3, 2023
29864_dirs_2023-05-03_32192d32-3889-417f-bc1a-081a4a124f87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2023-05-01
Reporting Person: MCGLYNN MARGARET G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | Stock Option (Right to Buy) | $342.73 | A | 3481 | Acquired | 2033-04-30 | Common Stock (3481) | Direct |
Footnotes
F1: Fully vested.
More from VERTEX PHARMACEUTICALS INC / MA
Major Shareholding Notification
2026
May 14
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13